Y0002208

Epinastine for system suitability A

European Pharmacopoeia (EP) Reference Standard

• Synonym(s): Epinastine hydrochloride, 9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride, WAL-801Cl
• Empirical Formula (Hill Notation): C₁₆H₁₅N₃ · HCl
• CAS Number: 108929-04-0
• Molecular Weight: 285.77
• MDL number: MFCD00933434
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• API family: epinastine
• manufacturer/tradename: EDQM
• storage temp.: 2-8°C
• SMILES string: Cl[H].NC1=NCC2N1c3ccccc3Cc4ccccc24
• InChI: 1S/C16H15N3.ClH/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16;/h1-8,15H,9-10H2,(H2,17,18);1H
• InChI key: VKXSGUIOOQPGAF-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Epinastine for system suitability A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem/physiol Actions

Epinastine hydrochloride is a non-sedating H1 histamine receptor antagonist.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS06
• Signal Word: Danger
• Hazard Statements: H301
• Precautionary Statements: P264 - P270 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral
• Storage Class Code: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable